In principle, mRNA vaccines are ideal for health emergencies as they can be quickly mass produced using a template. The problem is that current cell-based template production methods take too long, ...

The molecule is also being tested in over 100 vaccine clinical trials. Rising QS-21 demand from the pharmaceutical industry ...

The poultry supply chain has perfected the art of turning living creatures into nuggets with more chickens slaughtered in two ...

Drugmaker Pfizer posted a better-than-expected fourth-quarter profit on Thursday, helped by cost cuts it began last year as ...

(Reuters) -Drugmaker Pfizer posted a better than expected fourth quarter profit on Thursday, helped by cost cuts and a ...

This would reverse progress toward curbing drug shortages. AstraZeneca scrapped plans to invest $558.3 million in its vaccine ...

announced today that it has received approval for a partial amendment to the manufacturing and marketing approval of "KOSTAIVE ® for Intramuscular Injection," a self-amplifying mRNA vaccine for ...

Meiji Seika Pharma Receives Approval for Adding Domestic Manufacturing Sites in Japan for KOSTAIVE®, a Self-amplifying mRNA Vaccine Against COVID-19 Meiji Seika Pharma Co., Ltd. (Headquarters ...

announced today that it has received approval for a partial amendment to the manufacturing and marketing approval of “KOSTAIVE ® for Intramuscular Injection,” a self-amplifying mRNA vaccine for ...

With a significant rise in milk production costs seen between 2019 and 2024, dairy farmers across multiple regions are feeling the pressure. Credit: PeopleImages.com – Yuri A/Shutterstock. Global milk ...

Kennedy Jr. scrambled to fend off tough questions about his record of anti-vaccine statements and views ... who asked how he hoped to cut health costs and improve care and outcomes as Trump ...